Details for New Drug Application (NDA): 071126
✉ Email this page to a colleague
NDA 071126 describes PROPRANOLOL HYDROCHLORIDE & HYDROCHLOROTHIAZIDE, which is a drug marketed by Duramed Pharms Barr and is included in two NDAs. Additional details are available on the PROPRANOLOL HYDROCHLORIDE & HYDROCHLOROTHIAZIDE profile page.
The generic ingredient in PROPRANOLOL HYDROCHLORIDE & HYDROCHLOROTHIAZIDE is hydrochlorothiazide; propranolol hydrochloride. There are thirty-two drug master file entries for this compound. Additional details are available on the hydrochlorothiazide; propranolol hydrochloride profile page.
The generic ingredient in PROPRANOLOL HYDROCHLORIDE & HYDROCHLOROTHIAZIDE is hydrochlorothiazide; propranolol hydrochloride. There are thirty-two drug master file entries for this compound. Additional details are available on the hydrochlorothiazide; propranolol hydrochloride profile page.
Summary for 071126
| Tradename: | PROPRANOLOL HYDROCHLORIDE & HYDROCHLOROTHIAZIDE |
| Applicant: | Duramed Pharms Barr |
| Ingredient: | hydrochlorothiazide; propranolol hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 25MG;40MG | ||||
| Approval Date: | Mar 2, 1987 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
